A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety
Clinical trial NCT00364533 · TERMINATED
Trial details
- NCT number
- NCT00364533
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-12-01
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.